Literature DB >> 19691645

Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.

K U Sorenmo1, V M Kristiansen, M A Cofone, F S Shofer, A-M Breen, M Langeland, C M Mongil, A M Grondahl, J Teige, M H Goldschmidt.   

Abstract

This study describes the clinical and histopathological findings in dogs with mammary gland tumours, and compares the histopathological and clinical evidence consistent with progression from benign to malignant to human breast cancer epidemiology. Clinical and histopathological data on 90 female dogs with 236 tumours was included. Dogs with malignant tumours were significantly older than dogs with benign tumours (9.5 versus 8.5 years), P = 0.009. Malignant tumours were significantly larger than benign tumours (4.7 versus 2.1 cm), P = 0.0002. Sixty-six percent had more than one tumour, and evidence of histological progression was noted with increasing tumour size. Dogs with malignant tumours were significantly more likely to develop new primary tumours than dogs with benign tumours, P = 0.015. These findings suggest that canine mammary tumours progress from benign to malignant; malignant tumours may be the end stage of a histological continuum with clinical and histopathological similarities to human breast carcinogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 19691645     DOI: 10.1111/j.1476-5829.2009.00184.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  33 in total

1.  Clinical staging in bitches with mammary tumors: Influence of type and histological grade.

Authors:  Lígia F Gundim; Camila P de Araújo; William T Blanca; Ednaldo C Guimarães; Alessandra A Medeiros
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

2.  In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.

Authors:  Samantha Guillemette; Charlène Rico; Philippe Godin; Derek Boerboom; Marilène Paquet
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-08-18       Impact factor: 2.673

Review 3.  Infection and cancer in multicellular organisms.

Authors:  Paul W Ewald; Holly A Swain Ewald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

4.  MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.

Authors:  Eman S Ramadan; Noha Y Salem; Ibrahim A Emam; Naglaa A AbdElKader; Haithem A Farghali; Marwa S Khattab
Journal:  Vet Res Commun       Date:  2021-11-17       Impact factor: 2.459

5.  Epidemiology of canine mammary tumours on the Canary Archipelago in Spain.

Authors:  José Rodríguez; Ángelo Santana; Pedro Herráez; David R Killick; Antonio Espinosa de Los Monteros
Journal:  BMC Vet Res       Date:  2022-07-11       Impact factor: 2.792

6.  Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.

Authors:  Erika Michel; Stefanie K Feldmann; Mariusz P Kowalewski; Carla Rohrer Bley; Alois Boos; Franco Guscetti; Iris M Reichler
Journal:  BMC Vet Res       Date:  2012-05-30       Impact factor: 2.741

7.  Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.

Authors:  Michèle Spoerri; Franco Guscetti; Sonja Hartnack; Alois Boos; Christine Oei; Orsolya Balogh; Renata M Nowaczyk; Erika Michel; Iris M Reichler; Mariusz P Kowalewski
Journal:  BMC Vet Res       Date:  2015-09-15       Impact factor: 2.741

8.  Prevalence of the Prefoldin Subunit 5 Gene Deletion in Canine Mammary Tumors.

Authors:  Silvia Hennecke; Julia Beck; Kirsten Bornemann-Kolatzki; Stephan Neumann; Hugo Murua Escobar; Ingo Nolte; Susanne Conradine Hammer; Marion Hewicker-Trautwein; Johannes Junginger; Franz-Josef Kaup; Bertram Brenig; Ekkehard Schütz
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

9.  Five markers useful for the distinction of canine mammary malignancy.

Authors:  Karol M Pawłowski; Henryk Maciejewski; Kinga Majchrzak; Izabella Dolka; Jan A Mol; Tomasz Motyl; Magdalena Król
Journal:  BMC Vet Res       Date:  2013-07-11       Impact factor: 2.741

10.  Development of new therapy for canine mammary cancer with recombinant measles virus.

Authors:  Koichiro Shoji; Misako Yoneda; Tomoko Fujiyuki; Yosuke Amagai; Akane Tanaka; Akira Matsuda; Kikumi Ogihara; Yuko Naya; Fusako Ikeda; Hiroshi Matsuda; Hiroki Sato; Chieko Kai
Journal:  Mol Ther Oncolytics       Date:  2016-01-13       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.